| Genetic and epigenetic alterations in bladder cancer HT Li, CE Duymich, DJ Weisenberger, G Liang International neurourology journal 20 (Suppl 2), S84, 2016 | 75 | 2016 |
| Knock-out of Arabidopsis AtNHX4 gene enhances tolerance to salt stress HT Li, H Liu, XS Gao, H Zhang Biochemical and biophysical research communications 382 (3), 637-641, 2009 | 67 | 2009 |
| Integrative epigenetic analysis reveals therapeutic targets to the DNA methyltransferase inhibitor guadecitabine (SGI‐110) in hepatocellular carcinoma M Liu, L Zhang, H Li, T Hinoue, W Zhou, H Ohtani, A El‐Khoueiry, ... Hepatology 68 (4), 1412-1428, 2018 | 57 | 2018 |
| Saccharomyces cerevisiae MHF complex structurally resembles the histones (H3-H4) 2 heterotetramer and functions as a heterotetramer H Yang, T Zhang, Y Tao, L Wu, H Li, J Zhou, C Zhong, J Ding Structure 20 (2), 364-370, 2012 | 26 | 2012 |
| DNMT and EZH2 inhibitors synergize to activate therapeutic targets in hepatocellular carcinoma L Zhang, HT Li, R Shereda, Q Lu, DJ Weisenberger, C O'Connell, ... Cancer letters 548, 215899, 2022 | 25 | 2022 |
| Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy HT Li, L Xu, DJ Weisenberger, M Li, W Zhou, CC Peng, K Stachelek, ... Nature communications 13 (1), 5523, 2022 | 24 | 2022 |
| Epigenetic plasticity potentiates a rapid cyclical shift to and from an aggressive cancer phenotype T Xu, HT Li, J Wei, M Li, TC Hsieh, YT Lu, R Lakshminarasimhan, R Xu, ... International journal of cancer 146 (11), 3065-3076, 2020 | 16 | 2020 |
| Independent manipulation of histone H3 modifications in individual nucleosomes reveals the contributions of sister histones to transcription Z Zhou, YT Liu, L Ma, T Gong, YN Hu, HT Li, C Cai, LL Zhang, G Wei, ... Elife 6, e30178, 2017 | 15 | 2017 |
| Yeast Hmt1 catalyses asymmetric dimethylation of histone H3 arginine 2 in vitro. HT Li, T Gong, Z Zhou, YT Liu, X Cao, Y He, CD Chen, JQ Zhou Biochemical Journal, 2015 | 15 | 2015 |
| Characterizing DNA methylation signatures and their potential functional roles in Merkel cell carcinoma H Gujar, A Mehta, HT Li, YC Tsai, X Qiu, DJ Weisenberger, MG Jasiulionis, ... Genome Medicine 13, 1-17, 2021 | 12 | 2021 |
| Tethering telomerase to telomeres increases genome instability and promotes chronological aging in yeast J Liu, MH He, J Peng, YM Duan, YS Lu, Z Wu, T Gong, HT Li, JQ Zhou Aging (Albany NY) 8 (11), 2827, 2016 | 11 | 2016 |
| Telomerase variants in patients with cirrhosis awaiting liver transplantation V Chiu, R Hogen, L Sher, N Wadé, D Conti, A Martynova, H Li, G Liang, ... Hepatology 69 (6), 2652-2663, 2019 | 9 | 2019 |
| RNA mis-splicing drives viral mimicry response after DNMTi therapy in SETD2-mutant kidney cancer HT Li, HJ Jang, K Rohena-Rivera, M Liu, H Gujar, J Kulchycki, S Zhao, ... Cell reports 42 (1), 2023 | 6 | 2023 |
| Albumin levels predict prognosis in advanced renal cell carcinoma treated with tyrosine kinase inhibitors: A systematic review and meta-analysis X Zhou, G Fu, X Zu, Z Xu, HT Li, A D'souza, V Tulpule, DI Quinn, ... Urologic Oncology: Seminars and Original Investigations 40 (1), 12. e13-12. e22, 2022 | 6 | 2022 |
| SETD2 Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer X Zhou, Y Sekino, HT Li, G Fu, Z Yang, S Zhao, H Gujar, X Zu, ... Cancer Research 83 (22), 3813-3826, 2023 | 1 | 2023 |
| Loss of SETD2 sensitizes kidney cancer cells to DNA methylation inhibitors by inducing viral mimicry and RNA mis-splicing HT Li, HS Jang, K Rohena-Rivera, H Gujar, M Liu, J Kulchycki, X Zhou, ... Cancer Research 82 (12_Supplement), 3618-3618, 2022 | | 2022 |
| SETD2 aberrancy enhanced the synergetic anti-tumor effects of DNA hypomethylating agents and PARP inhibitors in aggressive clear cell renal cell carcinoma X Zhou, G Fu, HT Li, H Gujar, DJ Weisenberger, DI Quinn, B Han, G Liang Cancer Research 82 (12_Supplement), 3736-3736, 2022 | | 2022 |
| Identifying DNA methylation signatures of retinoblastoma via aqueous humor, a novel ocular liquid biopsy L Xu, H Li, D Weisenberger, G Liang, JL Berry Investigative Ophthalmology & Visual Science 63 (7), 3574–A0003-3574–A0003, 2022 | | 2022 |
| The mutated chromatin modifier gene, H3F3AK27M, is a druggable target of DNA hypomethylating agents in pediatric high-grade glioma H Gujar, L Zhang, HT Li, H Otani, DJ Weisenberger, A Erdreich-Epstein, ... Cancer Research 80 (16_Supplement), 462-462, 2020 | | 2020 |
